Oregon Public Employees Retirement Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,819	Closed	-$1.21M	–	1548
2023 Q3	$1.21M	Sell	6,819 -3,309	-33%	-$631K	0.02%	847
2023 Q2	$1.92M	Sell	10,128 -10,100	-50%	-$2M	0.02%	642
2023 Q1	$4.05M	Buy	20,228 +208	+1%	+$43.7K	0.05%	351
2022 Q4	$4.76M	Buy	+20,020	New	+$4.27M	0.06%	318
2020 Q4	–	Sell	-15,500	Closed	-$2.26M	–	1604
2020 Q3	$2.26M	Sell	15,500 -800	-5%	-$114K	0.03%	425
2020 Q2	$2.41M	Sell	16,300 -8,800	-35%	-$1.19M	0.04%	407
2020 Q1	$2.73M	Buy	+25,100	New	+$2.9M	0.05%	332
2018 Q2	–	Sell	-18,002	Closed	-$2.14M	–	1094
2018 Q1	$2.14M	Buy	18,002 +79	+0.4%	+$10.2K	0.03%	568
2017 Q4	$2.28M	Buy	+17,923	New	+$2.25M	0.03%	541
2016 Q3	–	Sell	-100	Closed	-$6K	–	927
2016 Q2	$6K	Hold	100	–	–	﹤0.01%	1021
2016 Q1	$6K	Hold	100	–	–	﹤0.01%	1017
2015 Q4	$9K	Hold	100	–	–	﹤0.01%	1022
2015 Q3	$8K	Hold	100	–	–	﹤0.01%	1022
2015 Q2	$12K	Buy	+100	New	+$11.9K	﹤0.01%	1025